Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
24.39
+0.32 (1.33%)
At close: Mar 30, 2026
SHE:003020 Market Cap
SHE:003020 has a market cap or net worth of 4.58 billion as of March 30, 2026. Its market cap has increased by 29.58% in one year.
Market Cap
4.58B
Enterprise Value
4.31B
Revenue
1.47B
Ranking
n/a
PE Ratio
28.32
Stock Price
24.39
Market Cap Chart
Since December 15, 2020, SHE:003020's market cap has increased from 3.09B to 4.58B, an increase of 48.34%. That is a compound annual growth rate of 7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 4.58B | -6.99% |
| Dec 31, 2025 | 4.92B | 42.42% |
| Dec 31, 2024 | 3.46B | -23.11% |
| Dec 29, 2023 | 4.49B | 13.63% |
| Dec 30, 2022 | 3.96B | -6.89% |
| Dec 31, 2021 | 4.25B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ChemPartner PharmaTech | 5.11B |
| PharmaResources (Shanghai) | 5.08B |
| Innovita Biological Technology | 4.92B |
| Beijing Bohui Innovation Biotechnology Group | 4.84B |
| Wuhan Hvsen Biotechnology | 4.80B |
| Beijing Scitop Bio-tech | 4.79B |
| Assure Tech (Hangzhou) | 4.71B |
| Hangzhou Biotest Biotech | 4.70B |